Try our Advanced Search for more refined results
Health
- 
									October 03, 2025
									Fed. Challenge To Ala. Pot Regulators Must Wait For State SuitAn Alabama federal judge has paused a prospective medical marijuana business's lawsuit that claims it was wrongfully denied a license in retaliation for litigation it initiated, saying he wants to see how things play out in a nearly identical state court case first. 
- 
									October 03, 2025
									Fla. Jury Hears Law Weakened DEA Efforts In Opioid CrisisA former U.S. Drug Enforcement Administration official testified Friday in a Florida state court trial in a lawsuit alleging that Walgreens, Walmart and CVS conspired to overdispense prescription painkillers, saying that a federal law passed in 2016 made it harder to investigate the companies' contribution to the opioid crisis. 
- 
									October 03, 2025
									6th Circ. Will Hear Ohio PBM Fight Arguments In DecemberThe Sixth Circuit will hear arguments from the state of Ohio and the pharmacy benefit managers it's accusing of colluding to raise the price of prescription medications in December to decide whether the matter belongs in state or federal court. 
- 
									October 03, 2025
									Vape Cos. Tell 5th Circ. FDA Erred On Flavored E-CigsMultiple vaping companies told the Fifth Circuit that the U.S. Food and Drug Administration overstepped its authority when it blocked approval of their flavored e-cigarettes since it skipped a full review of the available information, including the regulator's own survey data showing that minors aren't using them. 
- 
									October 03, 2025
									NIH Sets Patent License Policy Aimed At Promoting AccessThe National Institutes Of Health has implemented a new policy that was proposed during the Biden administration to require those seeking commercial licenses to NIH-owned patents to detail how they will promote patient access for new drugs or medical devices they develop. 
- 
									October 03, 2025
									Osborne Clarke France Hires Arbitration Practice HeadOsborne Clarke LLP's Paris office has appointed a commercial disputes lawyer from HMN & Partners to head its international arbitration practice, saying she brings expertise in the aerospace, aviation and defense sectors. 
- 
									October 03, 2025
									11th Circ. Pushes Forward Fla.'s ACA Trans Health AppealThe Eleventh Circuit resolved a jurisdictional question that will allow Florida to continue pursuing its challenge against Biden-era policies impacting Affordable Care Act coverage for gender-affirming care. 
- 
									October 03, 2025
									Nurse Staffing Exec Says Jury Misled In Wage-Fixing CaseA nurse staffing executive convicted of wage fixing and wire fraud is asking a Nevada federal court for a new trial, arguing that prosecutors misled the jury about a cooperating witness's leniency deal. 
- 
									October 03, 2025
									Cigna Inks $5.7M Ghost Network Suit SettlementCigna has struck a $5.7 million deal to settle a proposed class action alleging the insurer violated federal benefits law by advertising out-of-network providers as in-network to participants in benefit plans it administered, counsel for plaintiffs announced Friday. 
- 
									October 03, 2025
									Native Groups Urge Action As Shutdown Threatens ServicesFederal lawmakers and Native American nonprofits are calling for funding to continue certain services during the U.S. government shutdown, saying they're concerned about the disproportionate harm it could have on tribal communities. 
- 
									October 03, 2025
									Trump Admin Hit With Suit Over $100K H-1B FeesSeveral groups sued Friday in California federal court to block the Trump administration's recent action slapping on a $100,000 fee for H-1B visas, saying the new price tag was unconstitutionally ordered and will hurt more than just America's tech industry. 
- 
									October 03, 2025
									The Roberts Court At 20: How The Chief Is Reshaping AmericaTwenty years after John Roberts became the 17th chief justice of the United States, he faces a U.S. Supreme Court term that's looking transformative for the country and its institutions. How Justice Roberts and his colleagues navigate mounting distrust in the judiciary and set the boundaries of presidential authority appear increasingly likely to define his time leading the court. 
- 
									October 03, 2025
									Temple U., Cancer Center Beat Professor's Sex Bias SuitA Temple University cancer researcher can't sustain her suit alleging she was denied support for a grant application because she complained about a supervisor's unwelcome advances, a Pennsylvania federal judge ruled, saying one missed funding opportunity wasn't enough to show bias. 
- 
									October 03, 2025
									Ga. Insurer Can't Skirt Suit Over NC Captive Insurer's CollapseA Georgia insurance company can't slip out early from a fight over a defunct captive insurer's demise, a North Carolina Business Court judge has ruled, finding the company's owners directed actions into the Tar Heel state sufficient for it to be pulled into litigation there. 
- 
									October 02, 2025
									FDA OKs New Generic Abortion Pill, Drawing Conservative IreThe U.S. Food and Drug Administration has approved a second generic version of the abortion medication mifepristone, prompting outrage from anti-abortion groups and conservative politicians. 
- 
									October 02, 2025
									Wrongful-Death Damages Cap Case Remanded To Trial CourtA state appellate panel on Thursday cosigned a Georgia Supreme Court opinion ordering a trial judge to reexamine whether a $7.2 million jury award in a medical malpractice case should be reduced to $350,000, saying it incorrectly applied the high court's precedent. 
- 
									October 02, 2025
									Veteran Services Co. Must Face Chancery Self-Dealing ClaimsA Delaware Chancery judge refused to dismiss fiduciary duty claims against a veterans services company's top executives, ruling that a shareholder who sued over the company's 2023 merger into a limited liability company adequately alleged that it may have been structured to shield its leaders from accountability. 
- 
									October 02, 2025
									NC Court Rejects McGuireWoods' Immunity In Defamation SuitA North Carolina appellate court dismissed an interlocutory appeal by McGuireWoods and a former partner in a defamation case over statements about an investigation into the onetime CEO of a managed care organization during a press conference, reiterating its opinion that the statements were "too far afield" to be considered part of a judicial proceeding. 
- 
									October 02, 2025
									Feds Eye Partial Pretrial Ruling In Regeneron FCA CaseThe government has urged a Massachusetts federal judge to rule that Regeneron Pharmaceuticals "naturally or foreseeably" caused providers to present false claims for its macular degeneration drug Eylea, arguing that it does not need to prove the tougher "but-for causation" standard for its theory of false certification. 
- 
									October 02, 2025
									NC Chief Judge Scolds Medical Supply Co.'s 'Rude' DemandA North Carolina federal judge on Wednesday threw out a medical supply company's suit over COVID-19 test kit profits based on the Chinese citizenship of one party, adding that the plaintiff's impatience with the court amid a judge shortage was "rude." 
- 
									October 02, 2025
									Colo. Healthcare Nonprofit Sues Gov. Over Medicaid CutsA Colorado healthcare nonprofit seeks a court order to reverse a recent executive order from Gov. Jared Polis which cut state Medicaid spending to pediatric behavioral therapy and autism therapy services. 
- 
									October 02, 2025
									AstraZeneca Asks Judge To Block Colorado's 340B Drug LawAstraZeneca urged a Colorado federal judge on Wednesday to block the enforcement of a recently enacted state law that aims to extend a federal drug discount program to certain pharmacies, saying the Colorado law is costly for manufacturers and preempted by federal law. 
- 
									October 02, 2025
									Fed. Circ. Affirms Cutting $10M Med Device IP Verdict To $1The Federal Circuit on Thursday said a lower court had properly reduced to $1 what had been a $10 million patent infringement verdict against Intuitive Surgical Inc., saying any amount between the two figures "would require improper guesswork," given the lack of evidence on damages. 
- 
									October 02, 2025
									Ill. Panel Backs Whistleblower's $3.5M Retaliation VerdictAn Illinois appellate panel on Wednesday affirmed a $3.5 million verdict for a man who claimed he was unlawfully fired from a southern Illinois hospital system for reporting Medicare and Medicaid fraud and abuse, saying jurors saw evidence he and others faced retaliation when they "called attention to what they believed to be unlawful conduct." 
- 
									October 02, 2025
									Ill. Panel Rejects Challenge To Abortion Coverage MandateIllinois' mandate that health policies issued in the state cover abortion care does not violate an Illinois religious freedom law, a state appeals court ruled, rejecting a Baptist organization's claims that the mandate "substantially burdened" its religious beliefs per the Illinois Religious Freedom Restoration Act. 
Expert Analysis
- 
								Series My Opera And Baseball Careers Make Me A Better Lawyer  Though participating in opera and the world of professional baseball often pulls me away from the office, my avocations improve my legal career by helping me perform under scrutiny, prioritize team success, and maintain joy and perspective at work, says Adam Unger at Herrick Feinstein. 
- 
								
								High Court ACA Ruling May Harm Preventative Care  The U.S. Supreme Court's decision in Kennedy v. Braidwood last week, ruling that the U.S. Department of Health and Human Services secretary has authority over an Affordable Care Act preventive care task force, risks harming the credibility of the task force and could open the door to politicians dictating clinical recommendations, says Michael Kolber at Manatt. 
- 
								
								8 Ways Lawyers Can Protect The Rule Of Law In Their Work  Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business. 
- 
								
								Is SEC Moving Away From Parallel Insider Trading Cases?  The U.S. Securities and Exchange Commission's apparent lack of follow-up in four recent criminal cases of insider trading brought by the Justice Department suggests the SEC may be reconsidering the expense and effort of bringing parallel civil charges for insider trading, say attorneys at Dentons. 
- 
								
								Rising Enforcement Stakes For Pharma Telehealth Platforms.jpg)  Two pieces of legislation recently introduced in Congress could transform the structure and promotion of telehealth arrangements as legislators increasingly scrutinize direct-to-consumer advertising platforms, potentially paving the way for a new U.S. Food and Drug Administration policy with bipartisan support, say attorneys at Sheppard Mullin. 
- 
								Series Law School's Missed Lessons: Communicating With Clients  Law school curricula often overlook client communication procedures, and those who actively teach this crucial facet of the practice can create exceptional client satisfaction and success, says Patrick Hanson at Wiggam Law. 
- 
								
								3 Judicial Approaches To Applying Loper Bright, 1 Year Later  In the year since the U.S. Supreme Court overturned Chevron deference in its Loper Bright Enterprises v. Raimondo decision, a few patterns have emerged in lower courts’ application of the precedent to determine whether agency actions are lawful, say attorneys at Husch Blackwell. 
- 
								
								Prepping For SEC's Changing Life Sciences Enforcement.jpg)  By proactively addressing several risk areas, companies in the life sciences sector can position themselves to minimize potential exposure under the U.S. Securities and Exchange Commission's return to back-to-basics enforcement focused on insider trading and fraud, say attorneys at Morgan Lewis. 
- 
								Series Adapting To Private Practice: From US Rep. To Boutique Firm  My transition from serving as a member of Congress to becoming a partner at a boutique firm has been remarkably smooth, in part because I never stopped exercising my legal muscles, maintained relationships with my former colleagues and set the right tone at the outset, says Mondaire Jones at Friedman Kaplan. 
- 
								Opinion IRS Should Work With Industry On Microcaptive Regs  The IRS should engage with microcaptive insurance owners to develop better regulations on these arrangements or risk the emergence of common law guidance as taxpayers with legitimate programs seek relief in the federal courts, says Dustin Carlson at SRA 831(b) Admin. 
- 
								
								How Providers Can Brace For Drug Pricing Policy Changes.jpg)  Though it's uncertain which provisions of the Trump administration's executive order aimed at addressing prescription drug costs will eventually be implemented, stakeholders can reduce potential negative outcomes by understanding pathways that could be used to effectuate the order's directives, say attorneys at McDermott. 
- 
								
								Discretionary Denial Rulings May Spur Calls For PTAB Reform  The U.S. Patent and Trademark Office's recent decision in iRhythm Technologies v. Welch Allyn, denying inter partes review based on the patent owner's settled expectations that the patent would not be challenged, could motivate patent holders to seek Patent Trial and Appeal Board reform to preserve patent quality without burdening owners, say attorneys at Dechert. 
- 
								
								Spinoff Transaction Considerations For Biotech M&A  Amid current market challenges, boards and management teams of biotech companies can consider several strategies for maximizing value should a spinoff opportunity arise, but not without significant advance planning and careful implementation, particularly in cases that might qualify as tax-free, say attorneys at Paul Hastings. 
- 
								
								Debunking 4 Misconceptions Around Texas' IV Therapy Law  Despite industry confusion, an IV therapy law enacted in Texas last week may actually be the most business-friendly regulatory development the medical spa industry has seen in recent years, says Keith Lefkowitz at Hendershot Cowart. 
- 
								Opinion Senate's 41% Litigation Finance Tax Would Hurt Legal System  The Senate’s latest version of the Big Beautiful Bill Act would impose a 41% tax on the litigation finance industry, but the tax is totally disconnected from the concerns it purports to address, and it would set the country back to a time when small plaintiffs had little recourse against big defendants, says Anthony Sebok at Cardozo School of Law.